(
out of
176
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Hospital North
Surgical Oncology
1950 Circle of Hope
Salt Lake City
,
UT
84112
University of Utah Hospital
Surgical Oncology
50 N Medical Dr
Salt Lake City
,
UT
84132
Board Certification
|
American Board of Surgery (Sub: Complex General Surgical Oncology)
American Board of Surgery (Sub: General Surgery)
|
Patient Rating
Patients consistently describe Dr. Sun as compassionate, approachable, and attentive, noting that he makes them feel heard and treated with respect. Many praise his clear, patient explanations of diagnoses, procedures, and options, and appreciate that he takes time to educate both patients and family members. Reviewers also highlight his competence and professionalism, describing him as knowledgeable, up to date, and confident while maintaining an excellent bedside manner. Several comments note that his positive demeanor and communication help ease anxiety and build trust during care.
Generated via Patient Reviews
5.0
/5
( out of
176 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Surgery
-Assistant Professor (Clinical) |
|---|---|
| Academic Divisions |
Surgical Oncology
|
| Board Certification |
American Board of Surgery (Sub: Complex General Surgical Oncology)
American Board of Surgery (Sub: General Surgery)
|
Education history
| Fellowship | Fox Chase Cancer Center at Temple University Hospital | Administrative Chief Fellow |
|---|---|---|
| Fellowship | Fox Chase Cancer Center at Temple University Hospital | Educational Chief Fellow |
| Fellowship | Complex General Surgical Oncology - Fox Chase Cancer Center at Temple University Hospital | Fellow |
| Chief Resident | General Surgery - Case Western Reserve University, University Hospitals Cleveland Medical Center | Chief Resident |
| Residency | General Surgery - Case Western Reserve University, University Hospitals Cleveland Medical Center | Resident |
| Fellowship | Surgical Oncology Research - H. Lee Moffitt Cancer Center & Research Institute | Fellow |
| Internship/Residency | General Surgery - State University of New York Health Science Center at Brooklyn | Intern/Resident |
| Professional Medical | Medicine - State University of New York Downstate College of Medicine | M.D. |
| Undergraduate | Arts, Music - Stony Brook University | B.A. |
Selected Publications
Journal Article
- Chatani PD, Fredette JD, Sun J, Thomas RP, Porpiglia AS, Greco SH, Reddy SS, Farma JM, Villano AM (2026). Redefining the Lymphadenectomy Standard to Avoid Under-Staging in Oncologic Colectomies. J Natl Compr Canc Netw.
- Jensen K, Sun J, Asare EA (2026). The Continued Clinical Relevance of Sentinel Lymph Node Biopsy in Modern Melanoma Management. Curr Surg Rep.
- Sun J, Hwang J, Fredette JD, Papai E, Miller L, Krempa J, Rives HD, Reddy SS (2025). Preoperative weight loss and postoperative pancreatic fistula risk affected by body mass index: a National Surgical Quality Improvement Program study. J Gastrointest Surg, 29(9), 102157.
- Sun J, Fredette JD, Hasler JS, Vu JV, Philp M, Poggio JL, Porpiglia AS, Greco SH, Reddy SS, Farma JM, Villano AM (2025). Effect of Rectal Cancer Treatment Timing Standardization on Patient Outcomes. Am J Clin Oncol, 48(6), 302-309.
- Kakish H, Sun J, Ammori JB, Hoehn RS, Rothermel LD (2024). First-line Immunotherapy for Metastatic Merkel Cell Carcinoma: Analysis of Real-world Survival Data and Practice Patterns. Am J Clin Oncol, 47(8), 357-362.
- Kakish H, Sun J, Zheng DX, Ahmed FA, Elshami M, Loftus AW, Ocuin LM, Ammori JB, Hoehn RS, Bordeaux JS, Rothermel LD (2023). Predictors of sentinel lymph node metastasis in very thin invasive melanomas. Br J Dermatol, 189(4), 419-426.
- Broman KK, Hughes TM, Bredbeck BC, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Oshea K, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Hotz M, Farma JM, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley GM, Hui JYC, Been L, Kruijff S, Sinco B, Sarnaik AA, Sondak VK, Zager JS, Dossett LA, International High Risk Melanoma Consortium (2023). International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers. Ann Surg, 277(5), e1106-e1115.
- Garg SK, Sun J, Kim Y, Whiting J, Sarnaik A, Conejo-Garcia JR, Phelps M, Weber JS, Mul JJ, Markowitz J (2023). Dichotomous Nitric Oxide-Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma. Cancers (Basel), 15(6).
- Tieniber AD, Shannon AB, Carr MJ, Sun J, Landa K, Baecher KM, Lynch K, Bartels HG, Panchaud R, Lowe MC, Slingluff CL, Jameson MJ, Tsai KY, Faries MB, Beasley GM, Sondak VK, Karakousis GC, Zager JS, Miura JT (2022). Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis. J Am Acad Dermatol, 88(1), 251-253.
- Carr MJ, Sun J, Adams WA, Dugan MM, Naqvi SMH, Kim Y, Messina JL, Gonzalez RJ, Zager JS, Mullinax JE (2023). Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific Mortality. Cancer Control, 30, 10732748231206957.
- Shannon AB, Straker RJ 3rd, Carr MJ, Sun J, Landa K, Baecher K, Lynch K, Bartels HG, Panchaud R, Keele LJ, Lowe MC, Slingluff CL, Jameson MJ, Tsai KY, Faries MB, Beasley GM, Sondak VK, Karakousis GC, Zager JS, Miura JT (2022). An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. Ann Surg Oncol, 29(11), 7033-7044.
- Eroglu Z, Broman KK, Thompson JF, Nijhuis A, Hieken TJ, Kottschade L, Farma JM, Hotz M, Deneve J, Fleming M, Bartlett EK, Sharma A, Dossett L, Hughes T, Gyorki DE, Downs J, Karakousis G, Song Y, Lee A, Berman RS, van Akkooi A, Stahlie E, Han D, Vetto J, Beasley G, Farrow NE, Hui JYC, Moncrieff M, Nobes J, Baecher K, Perez M, Lowe M, Ollila DW, Collichio FA, Bagge RO, Mattsson J, Kroon HM, Chai H, Teras J, Sun J, Carr MJ, Tandon A, Babacan NA, Kim Y, Naqvi M, Zager J, Khushalani NI (2022). Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection. J Immunother Cancer, 10(8).
- Holmberg CJ, Ny L, Hieken TJ, Block MS, Carr MJ, Sondak VK, rtenwall C, Katsarelias D, Dimitriou F, Menzies AM, Saw RP, Rogiers A, Straker RJ 3rd, Karakousis G, Applewaite R, Pallan L, Han D, Vetto JT, Gyorki DE, Tie EN, Vitale MG, Ascierto PA, Dummer R, Cohen J, Hui JY, Schachter J, Asher N, Helgadottir H, Chai H, Kroon H, Coventry B, Rothermel LD, Sun J, Carlino MS, Duncan Z, Broman K, Weber J, Lee AY, Berman RS, Teras J, Ollila DW, Long GV, Zager JS, van Akkooi A, Olofsson Bagge R (2022). The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study. Eur J Cancer, 169, 210-222.
- Carr MJ, Sun J, DePalo D, Rothermel LD, Song Y, Straker RJ, Baecher K, Louie RJ, Stahlie EHA, Wright GP, Naqvi SMH, Kim Y, Sarnaik AA, Karakousis GC, Lowe MC, Delman KA, van Akkooi ACJ, Ollila DW, Collichio F, Zager JS (2021). Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience. Ann Surg Oncol, 29(2), 791-801.
- Straker RJ 3rd, Carr MJ, Sinnamon AJ, Shannon AB, Sun J, Landa K, Baecher KM, Wood C, Lynch K, Bartels HG, Panchaud R, Lowe MC, Slingluff CL, Jameson MJ, Tsai K, Faries MB, Beasley GM, Sondak V, Karakousis GC, Zager JS, Miura JT (2021). Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma. Ann Surg Oncol, 28(12), 6995-7003.
- Broman KK, Bettampadi D, Prez-Morales J, Sun J, Kirichenko D, Carr MJ, Eroglu Z, Tarhini AA, Khushalani N, Schabath MB, Sarnaik A, Sondak VK, Zager JS (2021). Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection. Ann Surg Oncol, 28(12), 6978-6985.
- Sun J, Zhong X, Ma J, Sun W, Han HS, Soliman HH, Loftus LS, Costa RLB, Armaghani AJ, Soyano-Muller AE, Czerniecki BJ, Lee MC, Kiluk JV, Khakpour N, Hoover SJ, Laronga C, Khong HT (2021). Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia. Cancer Med, 10(21), 7665-7672.
- Straker RJ 3rd, Song Y, Sun J, Shannon AB, Cohen LS, Muradova E, Daou H, Krause K, Li S, Frederick DT, Rhodin KE, Brizel DM, Boland GM, Beasley GM, Wuthrick EJ, Sondak VK, Zager JS, Lin A, Lukens JN, Karakousis GC (2020). Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era. Ann Surg Oncol, 28(7), 3512-3521.
- Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS (2021). Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer, 127(13), 2251-2261.
- Sun J, Henry DA, Carr MJ, Yazdankhahkenary A, Laronga C, Lee MC, Hoover SJ, Sun W, Czerniecki BJ, Khakpour N, Kiluk JV (2020). Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization. Clin Breast Cancer, 21(3), e189-e193.
- Broman KK, Hughes TM, Dossett LA, Sun J, Carr MJ, Kirichenko DA, Sharma A, Bartlett EK, Nijhuis AA, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma J, Deneve JL, Fleming MD, Perez M, Baecher K, Lowe M, Bagge RO, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras RM, Teras J, Farrow NE, Beasley GM, Hui JY, Been L, Kruijff S, Boulware D, Sarnaik AA, Sondak VK, Zager JS, International High-Risk Melanoma Consortium (2020). Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. J Am Coll Surg, 232(4), 424-431.
- Mathias BJ, Sun J, Sun W, Zhou JM, Fulp WJ, Laronga C, Lee MC, Kiluk JV (2020). Surgeon Bias in the Management of Positive Sentinel Lymph Nodes. Clin Breast Cancer, 21(1), 74-79.
- Sun J, Mathias BJ, Laronga C, Sun W, Zhou JM, Fulp WJ, Kiluk JV, Lee MC (2021). Impact of Axillary Dissection Among Patients With Sentinel Node-Positive Breast Cancer Undergoing Mastectomy. J Natl Compr Canc Netw, 19(1), 40-47.
- Sun J, Mathias BJ, Sun W, Fulp WJ, Zhou JM, Laronga C, Loftus LS, Lee MC (2020). Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer? Ann Surg Oncol, 28(1), 320-329.
- Kolla AM, Vitiello GA, Friedman EB, Sun J, Potdar A, Daou H, Farrow NE, Farley CR, Vetto JT, Han D, Tariq M, Beasley GM, Contreras CM, Lowe M, Zager JS, Osman I, Berman RS, Liebman TN, Stein JA, Lee AY (2021). Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis. Cancer Control, 28, 10732748211053567.
- Lee AY, Friedman EB, Sun J, Potdar A, Daou H, Farrow NE, Farley CR, Vetto JT, Han D, Tariq M, Shapiro R, Beasley G, Contreras CM, Osman I, Lowe M, Zager JS, Berman RS (2020). The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma. Ann Surg Oncol, 27(13), 5259-5266.
- Sun J, Loftus LS, Lee MC (2020). ASO Author Reflections: The De-Escalation of Sentinel Node Biopsy for Breast Cancer. Ann Surg Oncol, 27(Suppl 3), 838-839.
- Carr MJ, Sun J, Kroon HM, Miura JT, Beasley GM, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Kirichenko DA, Potdar A, Daou H, Mullen D, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Smithers BM, Coventry BJ, Tyler DS, Thompson JF, Zager JS (2020). Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia. Ann Surg Oncol, 27(13), 5107-5118.
- Kenyon-Smith TJ, Kroon HM, Miura JT, Teras J, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Smithers BM, Barbour A, Coventry BJ, Tyler DS, Zager JS, Thompson JF (2020). Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study. Eur J Surg Oncol, 46(11), 2140-2146.
- Strang LR, Sun J, Sun W, Boulware D, Kiluk JV, Lee MC, Khazai L, Laronga C (2020). Characteristics of Microinvasive Ductal Carcinoma In Situ Versus Noninvasive and Invasive Breast Cancer. J Surg Res, 254, 378-383.
- Carr MJ, Sun J, Zager JS (2020). Isolated limb infusion: Institutional protocol and implementation. J Surg Oncol, 122(1), 99-105.
- Sun J, Gastman BR, McCahon L, Buchbinder EI, Puzanov I, Nanni M, Lewis JM, Carvajal RD, Singh-Kandah S, Desai AM, Raskin L, Nielson CM, Ismail R, Zager JS (2020). Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2). Melanoma Manag, 7(2), MMT41.
- Seminario-Vidal L, Kroshinsky D, Malachowski SJ, Sun J, Markova A, Beachkofsky TM, Kaffenberger BH, Ergen EN, Mauskar M, Bridges A, Calhoun C, Cardones AR, Chen ST, Chodosh J, Cotliar J, Davis MDP, DeNiro KL, Dominguez AR, Eljure-Tllez J, Femia A, Fox LP, Guda A, Mitchell C, Mostaghimi A, Ortega-Loayza AG, Owen C, Pasieka H, Rahnama-Moghadam S, Saeed HN, Saunderson RB, Shanbhag S, Sharon VR, Strowd L, Venkatesh S, Wanat KA, Wetter DA, Worswick S, Micheletti RG (2020). Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. J Am Acad Dermatol, 82(6), 1553-1567.
- Teras J, Kroon HM, Miura JT, Kenyon-Smith T, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Potdar A, Daou H, Sun J, Carr M, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Smithers BM, Barbour A, Tyler DS, Coventry BJ, Zager JS, Thompson JF (2020). International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients. Ann Surg Oncol, 27(5), 1420-1429.
- Sun J, Kirichenko DA, Chung JL, Carr MJ, Eroglu Z, Khushalani NI, Markowitz J, Messina JL, Sondak VK, Zager JS, Patel SY (2019). Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy. World J Surg, 44(4), 1283-1293.
- Miura JT, Dossett LA, Thapa R, Kim Y, Potdar A, Daou H, Sun J, Sarnaik AA, Zager JS (2019). Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes. Ann Surg Oncol, 27(1), 196-202.
- Sun J, Chen DT, Li J, Sun W, Yoder SJ, Mesa TE, Wloch M, Roetzheim R, Laronga C, Lee MC (2019). Development of Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk. J Surg Res, 245, 153-162.
- Carr MJ, Sun J, Cohen JB, Liu J, Serdiuk AA, Stewart SR, Doobay N, Duclos A, Seal DA, Choi J, Zager JS (2020). Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases. Cancer Control, 27(1), 1073274820983019.
- Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS (2019). Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Ann Surg Oncol, 26(8), 2486-2494.
- Perez MC, Sun J, Farley C, Han D, Sun AH, Narayan D, Lowe M, Delman KA, Messina JL, Gonzalez RJ, Sondak VK, Khushalani NI, Zager JS (2019). Management of intussusception in patients with melanoma. J Surg Oncol, 119(7), 897-902.
- Louie RJ, Perez MC, Jajja MR, Sun J, Collichio F, Delman KA, Lowe M, Sarnaik AA, Zager JS, Ollila DW (2019). Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience. J Am Coll Surg, 228(4), 644-649.
- Sun J, Kashan DL, Auguste JM, Chendrasekhar A (2017). Pyomyositis in the setting of complicated diverticulitis: case report. Int J Gen Med, 11, 11-14.
- Fang CH, Sun J, Jyung RW (2015). Malignant otitis externa. Ear Nose Throat J, 94(4-5), 136-8.
Review
- Sun J, Awad MA, Hwang J, Villano AM (2025). Molecular Biomarkers for the Diagnosis and Prognostication of Pancreatic Ductal Adenocarcinoma. [Review]. J Pers Med, 15(6).
- Sun J, Karasaki KM, Farma JM (2024). The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment. [Review]. Cancers (Basel), 16(3).
- Patel A, Carr MJ, Sun J, Zager JS (2021). In-transit metastatic cutaneous melanoma: current management and future directions. [Review]. Clin Exp Metastasis, 39(1), 201-211.
- Sun J, Carr MJ, Khushalani NI (2019). Principles of Targeted Therapy for Melanoma. [Review]. Surg Clin North Am, 100(1), 175-188.
- Carr MJ, Sun J, Eroglu Z, Zager JS (2019). An evaluation of encorafenib for the treatment of melanoma. [Review]. Expert Opin Pharmacother, 21(2), 155-161.
- Sun J, Kirichenko DA, Zager JS, Eroglu Z (2019). The emergence of neoadjuvant therapy in advanced melanoma. [Review]. Melanoma Manag, 6(3), MMT27.
- Malachowski SJ, Sun J, Chen PL, Seminario-Vidal L (2019). Diagnosis and Management of Cutaneous B-Cell Lymphomas. [Review]. Dermatol Clin, 37(4), 443-454.
- Moy A, Sun J, Ma S, Seminario-Vidal L (2019). Lymphomatoid Papulosis and Other Lymphoma-Like Diseases. [Review]. Dermatol Clin, 37(4), 471-482.
- Broman KK, Dossett LA, Sun J, Eroglu Z, Zager JS (2019). Update on BRAF and MEK inhibition for treatment of melanoma in metastatic, unresectable, and adjuvant settings. [Review]. Expert Opin Drug Saf, 18(5), 381-392.
- Sun J, Zager JS, Eroglu Z (2018). Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy. [Review]. Onco Targets Ther, 11, 9081-9089.
Book Chapter
- Elsolh B, Sun J, Reddy SS (2025). Palliative Interventions for Patients with Operable and Advanced Pancreatic and Periampullary Cancer. In Cameron JL, Cameron AM (Eds.), Current Surgical Therapy (15). Elsevier.
- Sun J, Kroeger JL, Markowitz J (2020). Introduction to Multiparametric Flow Cytometry and Analysis of High-Dimensional Data. In Markowitz J (Ed.), Translational Informatics for Therapeutic Development Methods and Protocols. Methods in Molecular Biology (2194, pp. 239-253). New York, NY: Humana.
- Sun J, Lee MC (2020). Clinical Presentation, Diagnosis and Prognosis of Pregnancy-Associated Breast Cancer. In Alipour S, Omranipour R (Eds.), Diseases of the Breast During Pregnancy and Lactation. Advances in Experimental Medicine and Biology (1252, pp. 87-93). Cham, Switzerland: Springer.
Letter
- Malachowski SJ, Moy A, Messina J, Chen YA, Sun J, Sokol L, Seminario-Vidal L (2021). Mapping cutaneous T-cell lymphoma in the state of Florida: A retrospective exploratory spatial analysis of incidence patterns. [Letter to the editor]. J Am Acad Dermatol, 86(1), 186-188.
- Sun J, Lee MC (2021). Response to Letter to the Editor: "Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?" by Todd Tuttle et al. [Letter to the editor]. Ann Surg Oncol, 28(9), 5444-5445.
Very good at explaining my diagnosis.
Dr. Sun was very helpful, very free to talk to regarding the procedure and keeping my daughter-in-law apprised of the ongoing procedure and how it went. Couldn't have asked for better care.
I found Dr. Sun to be very compassionate. He was able to somewhat ease my fears. He was concise in my plan of treatment going forward.
Dr. Sun was the best! - he seemed excited to participate in my care, took the time to discuss my concerns, spoke clearly about the procedure and i know i was not just another surgery for him. He made me feel very comfortable about the surgery and i am confident that he treats all patient.
Very helpful. Took time to explain and asked plenty of questions.
Dr. Sun is very approachable and attentive to my case, and takes the time to educate me so I can make informed decisions regarding my health.
very exellant in all catagories
Dr Sun was wonderful to work with and it was obvious to me that he cares about his patients, their health and recovery.
Caring, interested in having me understand the procedures and options. Competent.
Dr. Sun is terrific. He explains things in a way a non-medical person can understand them.
He's very smart, but also adept at explaining complex issues in layman's terms.
He has a positive demeanor which is what I need now!!
You know you have a great doctor when you go back home and you're telling your friends and family that if they have any skin cancer issues you've got just the guy for them. He is kind, patient, thoughtful, and it's clear that he cares about his patients a great deal, which is an impactful thing to know when you're dealing with cancer. We're so grateful Dr. Sun is doctor. Thank you Dr. Sun!
Dr Sun is a nice man with great people skills. He is very skilled and cares about his patients
Extremely knowledgeable, prepared, caring,
Dr. Sun is a compassionate competent physician not just a good surgeon. He is well educated, confident, up to date on the literature and a clear communicator. He looks at the patient and not his computer screen. These are things I appreciate, having practiced in a surgical specialty for over 50 years. His respect for his patients, their relatives and his staff is obvious. I highly recommend him. He is a valuable new addition to the U of Utah staff.
Dr. Sun took a lot of time to explain my test results and the upcoming procedure. He was very thorough and kind.
Highly professional while caring and very clearly competent and current. As a medical professional myself I appreciate the direct eye contact instead of the current preoccupation many docs have with the software on their computers!! I highly recommend Dr Sun. His communication skills are exceptional.
Great! Highly recommend Dr. Sun and his team.
Listened to me and answered my questions. Willing to provide options.
Dr son is knowledgeable, has a very pleasant bedside manner and speaks to patients and family with respect. We felt like we were treated with dignity and respect through the entire visit.